Orlando, FL – Pharmacy Brokers, a premier mergers and acquisitions firm specializing in the pharmacy industry, is excited to announce its successful facilitation of the acquisition of a U.S.-based international pharmaceutical exporter.
The acquired company is an FDA-registered and ISO 9001 certified exporter, providing comprehensive cold chain logistics and shipping services to hospitals, clinics, and pharmacies across 26 countries. With well-established relationships with pharmaceutical manufacturers and healthcare supply companies, the exporter excels in:
- Screening and credentialing of restricted drugs.
- Providing a dedicated, trained staff to respond to health professionals regarding medications.
- Monitoring the safety and efficacy of FDA-approved drugs.
The acquiring private investment firm will leverage its extensive expertise in pharmacy, export, and logistics, coupled with robust marketing capabilities, to expand the global reach of the acquired wholesale company. This strategic move aims to meet the surging international demand for medications.
The global market for the distribution and wholesale of pharmaceutical products was valued at $1.6 trillion in 2024, with an expected growth to $2.4 trillion by 2030. This significant market expansion underscores the critical need for efficient global pharmaceutical supply chains.
Reliable global distribution of pharmaceuticals is vital for patient healthcare outside the United States. A robust supply chain, spanning from manufacturer to exporter, certified importer, hospitals, clinics, and pharmacies, is essential. Ensuring product efficacy through proper handling, storage, and shipping is paramount.
Wholesaling and distributing medications globally demands strict regulatory compliance, robust supply chain integrity, and efficient, cost-effective logistics. Given that each importing country has its own unique, and often stringent, regulations, a knowledgeable staff is crucial for navigating these complex compliance requirements.
The demand for cold chain storage and shipping processes is rapidly increasing. Temperature-sensitive medications necessitate advanced, time-critical cold chain systems with sophisticated tracking capabilities to maintain their integrity.
As global life expectancies continue to rise, so too will the demand for international pharmaceutical products. Companies that invest in leading-edge technology and processes will be at the forefront of the wholesale pricing and distribution of medications and healthcare devices.
This pivotal acquisition was seamlessly facilitated by Pharmacy Brokers, a trusted name in pharmacy industry acquisitions. Pharmacy Brokers played a critical role in valuing the business, structuring the deal, and ensuring a smooth transition from seller to buyer.
This acquisition is expected to significantly strengthen the buyer’s presence in the international marketplace and enhance its growing portfolio of healthcare and logistics companies.
For more information, please contact:
Javid Owji, President of Pharmacy Brokers E-mail: info@PharmacyBrokers.com Web: https://pharmacybrokers.com
